FindTrial
Sign In

Discovery of biomarkers in the diagnosis and treatment of breast cancer

Discovery of biomarkers in the diagnosis and treatment of breast cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DOD-17011393
Enrollment
Unknown
Registered
2017-05-13
Start date
2017-05-16
Completion date
Unknown
Last updated
2017-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Gold Standard:Histology diagnosis
Index test:levels&#32
of&#32
estrogen&#32
and&#32
its&#32
toxic&#32
metabolites&#32
the&#32
expression&#32
phase&#32
II&#32
metabolic&#32
enzymes&#32
UGT

Sponsors

The affiliated hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 70 Years

Inclusion criteria

Inclusion criteria: Disease group: Women with primary breast cancer. Healthy control group: Age matched healthy women with the disease group, with no history of cancer and self-reported health.

Exclusion criteria

Exclusion criteria: Tobacco, alcohol and other substance abuse history; a clear diagnosis of type II diabetes mellitus; severe hypertension; long-term use of hormone drugs; nearly 5 years of gynecological malignancies.

Design outcomes

Primary

MeasureTime frame
E2, 2OHE2 and 4OHE2;SEN;SPE;ACC;ROC;—

Countries

China

Contacts

Public ContactXiaoxing Yin; Meng Guo

Xuzhou Medical University

yinxx@xzhmu.edu.cn+86 13605218523

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026